Trial intelligence / Profile preview

Tramadol and sufentanil combined with propofol for painless gastroscopy in young adults

ChiCTR2400084512Phase 4Recruiting

Sponsor
Xianyang First People's Hospital
Start
May 2024
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of tramadol, sufentanil and propofol in None (2 arms), sponsored by Xianyang First People's Hospital. Primary endpoint: Anesthetic effect. Started May 2024; status: recruiting.

02

Drugs

tramadolsufentanilpropofol

Beyond the preview

Go deeper on ChiCTR2400084512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400084512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call